fbpx New legislation introduced to address missed opportunity in recently-finalized Contact Lens Rule | Johnson & Johnson Vision New legislation introduced to address missed opportunity in recently-finalized Contact Lens Rule | Johnson & Johnson Vision Skip to main content

New legislation introduced to address missed opportunity in recently-finalized Contact Lens Rule

Dear Eye Health Advocates,

We’re writing with some exciting news.

On Thursday, September 17, Senator John Boozman (R-Ark.), the only optometrist serving in the U.S. Senate, introduced legislation to address missed opportunities by the Federal Trade Commission (FTC) to modernize the contact lens prescription verification process and reduce paperwork burdens for eye care professionals in the recently-finalized Contact Lens Rule.

This latest legislative action by Senator Boozman is the result of tireless advocacy actions led by Johnson & Johnson Vision Care, Inc., and our partners in the eye health industry. Through numerous visits with lawmakers on Capitol Hill, multiple Congressional letters to the FTC, and collective action through the Health Care Alliance for Patient Safety (APS), we have not let up in our advocacy efforts to keep your patients safe and preserve the patient-doctor relationship. Senator Boozman’s legislation is the culmination of many months of bipartisan action to address the challenges eye care professionals and patients face regarding the Contact Lens Rule.

Specifically, this legislation titled the Contact Lens Rule Modernization Act, would eliminate the use of robocalls to verify contact lens prescriptions, eliminate new requirements on prescription release, and instead have prescribers alert patients to their patient rights via signage placed within the prescriber’s clinic.

Johnson & Johnson Vision strongly supports these changes proposed by the bill, which would help ensure your patients receive their lenses as prescribed and ensure all patients have access to their contact lens prescription while reducing the administrative burden on eye care professionals.

We are committed to listening to you, your patients, and the eye care professional community. Together, we will continue leading advocacy to shape the future of eye care.

Our promise to you is that we will remain unwavering in pursuit of solutions to support you and your patients.

Finally, if you have not done so already, take action by liking and sharing our Vision to Action Facebook post on this key issue to amplify your voice and bring others into the conversation. Sign up for emails below to receive timely advocacy updates.

Continue to get your voice heard,

Mike Mayers, O.D., FAAO
Director, US Advocacy
Johnson & Johnson Vision Care, Inc.

Thomas Swinnen
President, North America
Johnson & Johnson Vision Care, Inc.